Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)
CNY 10.84
(0.18%)
CNY 10.84
(0.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.62 Billion CNY | -9.12% |
| 2022 | 1.79 Billion CNY | 14.36% |
| 2021 | 1.56 Billion CNY | 22.54% |
| 2020 | 1.27 Billion CNY | 16.92% |
| 2019 | 1.09 Billion CNY | 4.06% |
| 2018 | 1.05 Billion CNY | 45.83% |
| 2017 | 720.76 Million CNY | 34.91% |
| 2016 | 534.25 Million CNY | 14.02% |
| 2015 | 468.55 Million CNY | 12.74% |
| 2014 | 415.61 Million CNY | 3.84% |
| 2013 | 400.26 Million CNY | 20.45% |
| 2012 | 332.3 Million CNY | 26.51% |
| 2011 | 262.67 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 430.72 Million CNY | 4.13% |
| 2024 Q2 | 471.89 Million CNY | 9.56% |
| 2024 Q3 | 430.03 Million CNY | -8.87% |
| 2023 Q3 | 359.69 Million CNY | -14.04% |
| 2023 Q1 | 436.75 Million CNY | 0.55% |
| 2023 Q2 | 418.45 Million CNY | -4.19% |
| 2023 FY | 1.62 Billion CNY | -9.12% |
| 2023 Q4 | 413.62 Million CNY | 14.99% |
| 2022 FY | 1.79 Billion CNY | 14.36% |
| 2022 Q4 | 434.36 Million CNY | -10.32% |
| 2022 Q3 | 484.32 Million CNY | 7.51% |
| 2022 Q2 | 450.5 Million CNY | 6.55% |
| 2022 Q1 | 422.8 Million CNY | -6.89% |
| 2021 FY | 1.56 Billion CNY | 22.54% |
| 2021 Q2 | 392.9 Million CNY | 16.62% |
| 2021 Q4 | 454.09 Million CNY | 18.54% |
| 2021 Q3 | 383.06 Million CNY | -2.5% |
| 2021 Q1 | 336.9 Million CNY | -4.71% |
| 2020 Q3 | 342.04 Million CNY | 7.32% |
| 2020 Q2 | 318.72 Million CNY | 20.53% |
| 2020 Q1 | 264.43 Million CNY | -3.48% |
| 2020 FY | 1.27 Billion CNY | 16.92% |
| 2020 Q4 | 353.56 Million CNY | 3.37% |
| 2019 FY | 1.09 Billion CNY | 4.06% |
| 2019 Q1 | 238.72 Million CNY | -5.78% |
| 2019 Q2 | 303.88 Million CNY | 27.29% |
| 2019 Q3 | 277.18 Million CNY | -8.78% |
| 2019 Q4 | 273.95 Million CNY | -1.17% |
| 2018 Q2 | 266.79 Million CNY | 7.21% |
| 2018 FY | 1.05 Billion CNY | 45.83% |
| 2018 Q4 | 253.37 Million CNY | -10.17% |
| 2018 Q3 | 282.05 Million CNY | 5.72% |
| 2018 Q1 | 248.84 Million CNY | 23.29% |
| 2017 Q2 | 184.58 Million CNY | 38.76% |
| 2017 Q3 | 201.32 Million CNY | 9.07% |
| 2017 Q4 | 201.83 Million CNY | 0.25% |
| 2017 FY | 720.76 Million CNY | 34.91% |
| 2017 Q1 | 133.02 Million CNY | -28.86% |
| 2016 Q4 | 186.98 Million CNY | 44.39% |
| 2016 Q3 | 129.49 Million CNY | 10.01% |
| 2016 FY | 534.25 Million CNY | 14.02% |
| 2016 Q1 | 100.06 Million CNY | -18.28% |
| 2016 Q2 | 117.71 Million CNY | 17.64% |
| 2015 Q2 | 124.32 Million CNY | 18.93% |
| 2015 Q1 | 104.53 Million CNY | -8.35% |
| 2015 FY | 468.55 Million CNY | 12.74% |
| 2015 Q4 | 122.43 Million CNY | 4.41% |
| 2015 Q3 | 117.26 Million CNY | -5.68% |
| 2014 Q3 | 102.3 Million CNY | -18.02% |
| 2014 Q1 | 74.45 Million CNY | -34.85% |
| 2014 FY | 415.61 Million CNY | 3.84% |
| 2014 Q2 | 124.79 Million CNY | 67.6% |
| 2014 Q4 | 114.06 Million CNY | 11.49% |
| 2013 Q4 | 114.27 Million CNY | 12.61% |
| 2013 Q3 | 101.48 Million CNY | 0.0% |
| 2013 FY | 400.26 Million CNY | 20.45% |
| 2012 FY | 332.3 Million CNY | 26.51% |
| 2011 FY | 262.67 Million CNY | 0.0% |